Episode 53. Belantamab Makes a Comeback with Dr. Hang Quach

Released Wednesday, 13th November 2024

Good episode? Give it some love!

Episode 53. Belantamab Makes a Comeback with Dr. Hang Quach

Wednesday, 13th November 2024

Good episode? Give it some love!

Rate Episode

In this episode, we discuss the comeback of belantamab mafadotin in multiple myeloma with Dr. Hang Quach, along with some other important abstracts presented at EHA/ASCO 2024. Here are the studies we discussed:

1. DREAMM-7 RCT: Belantamab-Vd vs Daratumumab-Vd in relapsed MM. https://pubmed.ncbi.nlm.nih.gov/38828933/

2. DREAMM-8 RCT: Belantamab-Pd vs PVd in relapsed MM. https://pubmed.ncbi.nlm.nih.gov/38828951/

3. Long-term follow-up of CASSIOPEIA Trial: https://pubmed.ncbi.nlm.nih.gov/38889735/

4. Update on MRD data from PERSEUS Trial: https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.7502

Rate

Get this podcast via API

From The Podcast

Blood Cancer Talks

This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth. Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, BostonTweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk

Join Podchaser to...

Rate podcasts and episodes
Follow podcasts and creators
Create podcast and episode lists
& much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.

Unlock more with Podchaser Pro

Audience Insights

Contact Information

Demographics

Charts

Sponsor History

and More!

Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More